Ozempic predecessor suggests potential for GLP-1 drugs in ... - CNN
Jul 30, 2024 · The study, of 204 people with Alzheimer’s disease in the United Kingdom, found that those taking the diabetes drug liraglutide – an earlier medication in Ozempic’s class, which are known as GLP-1...
Weight loss drug liraglutide shows real promise for younger
Sep 10, 2024 · CNN — Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study. Doctors say it can be...
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide …
Jun 24, 2024 · Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza ®1 (liraglutide injection 1.8mg), in the United States.
Victoza: Generic GLP-1 Drug Similar to Ozempic Now Available - Healthline
Jul 3, 2024 · Teva Pharmaceuticals announced the launch of a generic form of Victoza (liraglutide), the first-ever generic GLP-1 drug to be made available in the United States.
GLP-1 Drug Liraglutide May Protect Against Dementia
PHILADELPHIA, July 30, 2024 — A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial data reported today at the Alzheimer’s Association International Conference ® (AAIC ®) …
FDA approves weight management drug for patients aged 12 …
The U.S. Food and Drug Administration has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older who are obese.
Novo Nordisk GLP-1 liraglutide may slow Alzheimer's progression
Jul 30, 2024 · An older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression of Alzheimer’s disease by protecting patients’ brains, according to data from a...
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Jul 28, 2016 · The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. In this double-blind trial, we...
A Randomized, Controlled Trial of Liraglutide for Adolescents …
Mar 31, 2020 · Liraglutide, a glucagon-like peptide 1 (GLP-1) analogue, increases the postprandial insulin level in a glucose-dependent manner, reduces glucagon secretion, delays gastric emptying, and induces...
Liraglutide - latest research news and features - Medical Xpress
For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA), liraglutide, is effective for weight loss, while preserving bone health...